Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Covid-19 vaccine patent legal battle heading to Court of Appeal Moderna, Pfizer and BioNTech are locked in dispute over the rights to vaccine technology patents.

After federal health officials made abrupt changes to US Covid-19 vaccine recommendations for pregnant women last month, there’s new confusion and uncertainty about who can get the shots — and ...

The new COVID-19 vaccine from Moderna, mNexspike, is made in a way that allows for a lower dose.

A small study of COVID vaccine aftereffects triggers a political and scientific storm A mass COVID vaccination site in San Bernardino in 2021, when the vaccines were first rolled out.

On Aug. 26, Moderna sued fellow vaccine developers Pfizer and BioNTech, two companies that partnered to create a COVID-19 shot. Moderna accused Pfizer and BioNTech of patent infringement when ...

A US jury has decided that Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu infringes a patent held by US biotech Seagen, awarding almost $42 million in damages. Seagen claims Enhertu ...

Penn expecting $467M windfall from COVID-19 vaccine royalty dispute At issue was how much the manufacturer could carve out to third parties before paying the university its stake of the profits in the ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s patents for its COVID-19 vaccine technology. The final written ...

The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair settled a lawsuit out of court in late December 2024.